SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) April 29, 2004
Inverness Medical Innovations, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware (State or other jurisdiction of incorporation) |
001-16789 (Commission file number) |
04-3565120 (IRS Employer Identification No.) |
||
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 (Address of principal executive offices) |
||||
Registrant's telephone number, including area code: (781) 647-3900
Not Applicable
(Former name or former address, if changed since last report)
| Exhibit Number |
Description |
|
|---|---|---|
| 99.1 | Press Release dated April 29, 2004, entitled "Inverness Medical Innovations Announces First Quarter 2004 Results" |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On April 29, 2004, Inverness Medical Innovations, Inc. issued a press release entitled "Inverness Medical Innovations Announces First Quarter 2004 Results," a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| INVERNESS MEDICAL INNOVATIONS, INC. | |||
BY: |
/s/ CHRISTOPHER J. LINDOP Christopher J. Lindop Chief Financial Officer |
||
Dated: April 29, 2004
3
| Exhibit Number |
Description |
|
|---|---|---|
| 99.1 | Press Release dated April 29, 2004, entitled "Inverness Medical Innovations Announces First Quarter 2004 Results" |
4